382 related articles for article (PubMed ID: 31870357)
1. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
[TBL] [Abstract][Full Text] [Related]
2. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
[TBL] [Abstract][Full Text] [Related]
3. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
4. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
5. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
6. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma.
Lu S; Sun C; Chen H; Zhang C; Li W; Wu L; Zhu J; Sun F; Huang J; Wang J; Zhen Z; Cai R; Sun X; Zhang Y; Zhang X
Cancer Manag Res; 2020; 12():12123-12136. PubMed ID: 33273853
[TBL] [Abstract][Full Text] [Related]
8. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
Zou Y; Ruan S; Jin L; Chen Z; Han H; Zhang Y; Jian Z; Lin Y; Shi N; Jin H
Med Sci Monit; 2020 Aug; 26():e925289. PubMed ID: 32863381
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma.
Xia T; Meng L; Zhao Z; Li Y; Wen H; Sun H; Zhang T; Wei J; Li F; Liu C
Cancer Cell Int; 2021 Nov; 21(1):634. PubMed ID: 34838000
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers.
Fang L; Liu Q; Cui H; Zheng Y; Wu C
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456460
[TBL] [Abstract][Full Text] [Related]
11. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis.
Meng Z; Wu J; Liu X; Zhou W; Ni M; Liu S; Guo S; Jia S; Zhang J
J Int Med Res; 2020 Jul; 48(7):300060520910019. PubMed ID: 32722976
[TBL] [Abstract][Full Text] [Related]
14. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
Li J; Wang Y; Wang X; Yang Q
World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
[TBL] [Abstract][Full Text] [Related]
15. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
[TBL] [Abstract][Full Text] [Related]
17. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
[TBL] [Abstract][Full Text] [Related]
18. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential biomarkers for colorectal cancer by clinical database analysis and Kaplan-Meier curves analysis.
Li C; Gao Y; Lu C; Guo M
Medicine (Baltimore); 2023 Feb; 102(6):e32877. PubMed ID: 36820595
[TBL] [Abstract][Full Text] [Related]
20. [Screening and verification of key genes in T-cell acute lymphoblastic leukemia].
Jiang GJ; Chen YH; Guo W; Zhang H; Zou L
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):261-267. PubMed ID: 29643030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]